Key Trends Shaping the Future Blood Stream Infection Testing Market From 2025-2034: Innovative Ethylenediaminetetraacetic Acid (EDTA)-Compatible Cartridges Improve Sepsis Diagnosis Accuracy And Efficiency

What industry-specific factors are fueling the growth of the blood stream infection testing market?
The rise in infectious diseases is predicted to drive the expansion of the blood stream infection testing market. These diseases are caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites. The upsurge in infectious disease rates can be attributed to various factors including widespread travel, urban development, climate alterations, resistance to antibiotics, and lack of complete vaccination coverage. Bloodstream infection testing plays a crucial role in diagnosing and distinguishing pathogens responsible for sepsis and other intensive infections, thereby facilitating precise and effective treatments. For example, the most recent World Malaria report released by the World Health Organization (WHO), a United Nations agency based in Switzerland, in December 2023, stated that the number of malaria cases increased to 249 million in 2022 from 244 million in 2021. The estimated mortality due to malaria was about 608,000 in 2022, slightly less than the 610,000 in 2021. Thus, the escalating prevalence of infectious diseases is spurring the growth of the blood stream infection testing market.

Get Your Blood Stream Infection Testing Market Report Here:
https://www.thebusinessresearchcompany.com/report/blood-stream-infection-testing-global-market-report

What Is the projected market size and growth rate for the blood stream infection testing market?
The blood stream infection testing market has experienced a swift expansion in the recent past. It is projected to escalate from $7.59 billion in 2024 to $8.49 billion in 2025, correspondingly achieving a compound annual growth rate (CAGR) of 11.9%. This growth observed in the historic duration can be traced back to factors such as the increased occurrence of infections contracted in hospitals, the surging resistance to antimicrobial medications, the rise in the elderly population, increased health care spending, and the growing prevalence of chronic ailments.

Expectations are high for the blood stream infection testing market to experience robust growth in the coming years. Forecasts predict a compound annual growth rate (CAGR) of 11.7%, which would lead to a projected size of $13.19 billion by 2029. The projected growth within this period can be associated with a higher demand for quick diagnostic tests, a growing inclination towards molecular diagnostics, an increasing emphasis on personalized medicine, government-led initiatives on infection control, and an escalating occurrence of multi-drug-resistant pathogens. Key trends for the forecast period comprise the rising implementation of AI in diagnostic tools, combining telemedicine with diagnostic services, an increased demand for home-based testing kits, the creation of multiplex diagnostic platforms, as well as growing collaborations between diagnostic firms and hospitals.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20514&type=smp

What new trends are reshaping the blood stream infection testing market and its opportunities?
Key players in the bloodstream infection testing market are concentrated on the invention of cutting-edge products such as blood testing cartridges to maintain their market dominance. Blood testing cartridges are one-use testing devices used for the evaluation of blood samples during diagnostic procedures. They encompass pre-loaded reagents and built-in sensors or microfluidic conduits that make it possible to detect distinct biomarkers, pathogens or conditions from a minor blood sample. As an example, Immunexpress Pty Ltd., an Australian molecular diagnostics firm, introduced the SeptiCyte RAPID cartridges in August 2022. These cartridges work with undiluted ethylenediaminetetraacetic acid (EDTA) blood as a certified sample type, which has shown a strong correlation with other blood collection methodologies via a multi-site European study. This progression enhances the precision and efficiency of diagnosing sepsis, providing scope for broader and faster clinical incorporation. This can potentially revolutionize patient care while simultaneously reducing healthcare expenditures.

What major market segments define the scope and growth of the blood stream infection testing market?
The blood stream infection testing market covered in this report is segmented -

1) By Product Type: Instruments, Reagents And Consumables, Software And Services
2) By Sample Type: Whole Blood, Blood Culture
3) By Technology: Polymerase Chain Reaction (PCR), Mass Spectroscopy, In Situ Hybridization, Other Technologies
4) By End-User: Hospitals And Diagnostic Centers, Laboratory Service Providers, Academic And Research Institutes, Other End-Users

Subsegments:
1) By Instruments: Blood Culture Systems, Automated Microbial Identification Systems, Molecular Diagnostic Instruments
2) By Reagents and Consumables: Blood Culture Media, Antimicrobial Susceptibility Testing Reagents, Nucleic Acid Extraction Kits
3) By Software and Services: Laboratory Information Management Systems (LIMS), Data Analysis Software, Maintenance And Support Services

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20514

Which region dominates the blood stream infection testing market?
North America was the largest region in the blood stream infection testing market in 2024. The regions covered in the blood stream infection testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the blood stream infection testing industry growth?
Major companies operating in the blood stream infection testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Danaher Corporation, Siemens Healthcare Private Limited, Becton Dickinson and Company (BD), Grifols S.A., Hologic Inc., BIOMÉRIEUX SA, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., DiaSorin S.p.A., Seegene Inc., Cepheid, Meridian Bioscience Inc., Biocartis NV, T2 Biosystems Inc., Molzym GmbH & Co. KG, Curetis GmbH, Accelerate Diagnostics Inc., OpGen Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20514&type=smp

What Is Covered In The Blood Stream Infection Testing Global Market Report?

•Market Size Forecast: Examine the blood stream infection testing market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the blood stream infection testing market for a structured understanding.
•Key Players Overview: Analyze major players in the blood stream infection testing market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the blood stream infection testing market.
•Segment Contributions: Evaluate how different segments drive overall growth in the blood stream infection testing market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the blood stream infection testing market.
•Industry Challenges: Identify potential risks and obstacles affecting the blood stream infection testing market.
•Competitive Landscape: Review strategic developments in the blood stream infection testing market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.